X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
4.430
+0.140 (3.26%)
At close: May 8, 2026, 4:00 PM EDT
4.350
-0.080 (-1.81%)
After-hours: May 8, 2026, 7:37 PM EDT

X4 Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-99.72-79.2-37.45-101.17-93.87-88.7
Depreciation & Amortization
1.021.280.80.420.510.5
Stock-Based Compensation
6.194.38.28.695.26.18
Other Adjustments
1.37-9.42-105.13-4.85.3212.61
Change in Receivables
-0.610.5-1.07---
Changes in Inventories
-1.55-1.66-2.82---
Changes in Accounts Payable
-6.08-2.98-0.291.233.431.17
Changes in Accrued Expenses
4.21-2.037.171.613.8-0.15
Changes in Unearned Revenue
-0.781.09----
Changes in Other Operating Activities
3.12.51-0.32-2.5-1.49-2.51
Operating Cash Flow
-92.85-85.62-130.9-96.51-77.1-70.91
Capital Expenditures
-1.5--0.33-0.06-0.1-0.62
Sale of Property, Plant & Equipment
--105---
Purchases of Intangible Assets
--3-7---
Purchases of Investments
-51.5-63.39-57.13-16.82--
Proceeds from Sale of Investments
82.0474.5426.452--
Investing Cash Flow
30.548.1566.99-14.88-0.1-0.62
Long-Term Debt Issued
--2022.5--
Long-Term Debt Repaid
----2.06-0.8-
Net Long-Term Debt Issued (Repaid)
--2020.44-0.8-
Issuance of Common Stock
235.82238.630.2968.71122.8476.25
Repurchase of Common Stock
-----0.01-2
Net Common Stock Issued (Repurchased)
235.82238.630.2968.71122.8374.25
Other Financing Activities
----0.63-4.8-
Financing Cash Flow
238.63238.6320.2988.52117.2374.25
Effect of Exchange Rate Changes on Cash and Cash Equivalents
0.120.21-0.160.1-0.11-0.32
Net Cash Flow
176.45161.38-43.77-22.7839.922.41
Free Cash Flow
-94.35-85.62-131.23-96.57-77.21-71.52
FCF Margin
-1046.69%-243.84%-5132.07%---
Free Cash Flow Per Share
-1.31-2.02-19.58-16.29-36.46-83.33
Levered Free Cash Flow
-101.3-81-13.24-80.03-85.97-76.37
Unlevered Free Cash Flow
-99.33-88.72-244.24-106.9-82.47-86.74
Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q